SyMap Medical
Suzhou
About SyMap Medical
SyMap is dedicated to developing a proprietary, catheter-based renal mapping and ablation system for renal denervation therapy to treat hypertension and other diseases, such as heart failure, arrhythmia, and renal failure.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $110.1M
- Funding stage: Late Stage Venture
- Last round: Series E (Dec 2021)
- Website: symapmedical.com
Industries & Categories
Biotechnology, Health Care, Medical Device
Canonical: https://fsome.com/organization/symap-medical-46138 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.